SI3094616T1 - Uporaba sestavka, ki vsebuje gliceril tribenzoat pri nevrodegenerativnih boleznih - Google Patents
Uporaba sestavka, ki vsebuje gliceril tribenzoat pri nevrodegenerativnih boleznihInfo
- Publication number
- SI3094616T1 SI3094616T1 SI201531511T SI201531511T SI3094616T1 SI 3094616 T1 SI3094616 T1 SI 3094616T1 SI 201531511 T SI201531511 T SI 201531511T SI 201531511 T SI201531511 T SI 201531511T SI 3094616 T1 SI3094616 T1 SI 3094616T1
- Authority
- SI
- Slovenia
- Prior art keywords
- containing composition
- neurodegenerative disorders
- glyceryl tribenzoate
- tribenzoate
- glyceryl
- Prior art date
Links
- HIZCTWCPHWUPFU-UHFFFAOYSA-N Glycerol tribenzoate Chemical compound C=1C=CC=CC=1C(=O)OCC(OC(=O)C=1C=CC=CC=1)COC(=O)C1=CC=CC=C1 HIZCTWCPHWUPFU-UHFFFAOYSA-N 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461928622P | 2014-01-17 | 2014-01-17 | |
| EP15737329.1A EP3094616B1 (en) | 2014-01-17 | 2015-01-16 | The use of glyceryl tribenzoate containing composition in neurodegenerative disorders |
| PCT/US2015/011798 WO2015109215A1 (en) | 2014-01-17 | 2015-01-16 | The use of a benzoate containing composition in urea cycle disorders and neurodegenerativre disordrs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3094616T1 true SI3094616T1 (sl) | 2021-07-30 |
Family
ID=53543490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201531511T SI3094616T1 (sl) | 2014-01-17 | 2015-01-16 | Uporaba sestavka, ki vsebuje gliceril tribenzoat pri nevrodegenerativnih boleznih |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9968582B2 (https=) |
| EP (1) | EP3094616B1 (https=) |
| JP (2) | JP6836905B2 (https=) |
| CA (1) | CA2936548C (https=) |
| CY (1) | CY1124115T1 (https=) |
| DK (1) | DK3094616T3 (https=) |
| ES (1) | ES2853974T3 (https=) |
| HR (1) | HRP20210361T1 (https=) |
| HU (1) | HUE053671T2 (https=) |
| LT (1) | LT3094616T (https=) |
| PL (1) | PL3094616T3 (https=) |
| PT (1) | PT3094616T (https=) |
| RS (1) | RS61611B1 (https=) |
| SI (1) | SI3094616T1 (https=) |
| SM (1) | SMT202100074T1 (https=) |
| WO (1) | WO2015109215A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA202090666A1 (ru) * | 2017-10-06 | 2020-08-05 | Раш Юниверсити Медикал Сентер | Применение содержащей бензоат композиции для лечения глициновой энцефалопатии |
| JP7034314B2 (ja) * | 2017-11-22 | 2022-03-11 | 潔欣 林 | うつ病を予防または治療するための安息香酸またはその塩および誘導体 |
| US12478598B2 (en) | 2019-02-25 | 2025-11-25 | Rush University Medical Center | Compositions including cinnamic acid and methods of use thereof |
| CN114502154A (zh) * | 2019-07-16 | 2022-05-13 | 拉什大学医学中心 | 含苯甲酸酯的组合物治疗神经退行性疾病的用途 |
| CN116390761A (zh) * | 2020-10-28 | 2023-07-04 | 拉什大学医学中心 | 肉桂酸苄酯组合物在治疗甘氨酸脑病和尿素循环障碍中的应用 |
| CA3205005A1 (en) * | 2020-12-16 | 2022-06-23 | Rush University Medical Center | Administration of glycerol tribenzoate and glycerol phenylbutyrate for treatment of neurodegenerative and urea cycle disorders |
| JP2025503457A (ja) * | 2021-12-16 | 2025-02-04 | ザ ユナイテッド ステイツ ガバメント アズ リプレゼンティド バイ ザ デパートメント オブ ヴェテランズ アフェアーズ | 神経系損傷及び障害の治療のための安息香酸塩 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284647A (en) * | 1980-03-31 | 1981-08-18 | The Johns Hopkins University | Process for waste nitrogen removal |
| WO2008083226A2 (en) | 2006-12-28 | 2008-07-10 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
-
2015
- 2015-01-16 WO PCT/US2015/011798 patent/WO2015109215A1/en not_active Ceased
- 2015-01-16 CA CA2936548A patent/CA2936548C/en active Active
- 2015-01-16 PL PL15737329T patent/PL3094616T3/pl unknown
- 2015-01-16 DK DK15737329.1T patent/DK3094616T3/da active
- 2015-01-16 US US15/110,702 patent/US9968582B2/en active Active
- 2015-01-16 HR HRP20210361TT patent/HRP20210361T1/hr unknown
- 2015-01-16 SI SI201531511T patent/SI3094616T1/sl unknown
- 2015-01-16 EP EP15737329.1A patent/EP3094616B1/en active Active
- 2015-01-16 RS RS20210230A patent/RS61611B1/sr unknown
- 2015-01-16 SM SM20210074T patent/SMT202100074T1/it unknown
- 2015-01-16 ES ES15737329T patent/ES2853974T3/es active Active
- 2015-01-16 JP JP2016565117A patent/JP6836905B2/ja active Active
- 2015-01-16 PT PT157373291T patent/PT3094616T/pt unknown
- 2015-01-16 HU HUE15737329A patent/HUE053671T2/hu unknown
- 2015-01-16 LT LTEP15737329.1T patent/LT3094616T/lt unknown
-
2019
- 2019-10-18 JP JP2019191224A patent/JP2020037558A/ja active Pending
-
2021
- 2021-03-09 CY CY20211100204T patent/CY1124115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1124115T1 (el) | 2022-05-27 |
| EP3094616B1 (en) | 2020-12-23 |
| US9968582B2 (en) | 2018-05-15 |
| ES2853974T3 (es) | 2021-09-20 |
| JP2017505811A (ja) | 2017-02-23 |
| SMT202100074T1 (it) | 2021-05-07 |
| CA2936548A1 (en) | 2015-07-23 |
| US20160331714A1 (en) | 2016-11-17 |
| EP3094616A1 (en) | 2016-11-23 |
| HRP20210361T1 (hr) | 2021-04-16 |
| RS61611B1 (sr) | 2021-04-29 |
| CA2936548C (en) | 2022-08-30 |
| JP2020037558A (ja) | 2020-03-12 |
| HUE053671T2 (hu) | 2021-07-28 |
| LT3094616T (lt) | 2021-04-12 |
| PL3094616T3 (pl) | 2021-05-31 |
| WO2015109215A1 (en) | 2015-07-23 |
| JP6836905B2 (ja) | 2021-03-03 |
| EP3094616A4 (en) | 2017-08-23 |
| PT3094616T (pt) | 2021-03-03 |
| DK3094616T3 (da) | 2021-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252477A0 (en) | 2-aminopyrimidine compound, pharmaceutical structure and its use | |
| PT3513809T (pt) | Composição medicinal compreendendo tivozanib | |
| GB201411197D0 (en) | Composition and use thereof | |
| GB201403093D0 (en) | Therapeutic compounds and their use | |
| PT3018183T (pt) | Composição à base de halo-olefina e sua utilização | |
| SG11201608217PA (en) | Fatty acid composition and use thereof | |
| GB201408080D0 (en) | Skin care composition | |
| ZA201704830B (en) | Cosmetic sunscreen composition | |
| SG11201605366QA (en) | Pharmaceutical composition containing pyridylaminoacetic acidcompound | |
| PL3094616T3 (pl) | Zastosowanie kompozycji zawierającej benzoesan w zaburzeniach cyklu mocznikowego i chorobach neurodegeneracyjnych | |
| PL3215157T3 (pl) | Apilimod do stosowania w leczeniu czerniaka | |
| PT3160464T (pt) | 6-hidroxibuspirona para uso no tratamento de transtornos do movimento | |
| ZA201606264B (en) | Personal care composition | |
| SG11201602573RA (en) | Skin cosmetic composition | |
| PL3102187T3 (pl) | Stabilne kompozycje farmaceutyczne zawierające sitagliptynę w postaci tabletek o natychmiastowym uwalnianiu | |
| GB201408079D0 (en) | Skin care composition | |
| GB201411196D0 (en) | Composition and use thereof | |
| IL248735B (en) | Preparations containing glycolipid for use in the treatment of tumors | |
| IL252447A0 (en) | Compound for oral care | |
| IL249852A0 (en) | Rubbing composition for oral treatment | |
| IL252994A0 (en) | Compound for oral care | |
| SG11201702334SA (en) | External preparation composition containing s-flurbiprofen | |
| ZA201606391B (en) | Personal care composition | |
| GB201513543D0 (en) | Compositions for use in the treatment of diabetes | |
| SG11201607201TA (en) | Hair cosmetic composition |